[]

Find Clinical Drug Pipeline Developments & Deals for Ribose

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          RiboCor

                          Country arrow
                          The MedTech Conference
                          Not Confirmed

                          RiboCor

                          Country arrow
                          The MedTech Conference
                          Not Confirmed

                          Details : D-Ribose is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Heart Failure.

                          Product Name : Undisclosed

                          Product Type : Carbohydrate

                          Upfront Cash : Inapplicable

                          May 21, 2013

                          Lead Product(s) : Ribose

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Phase II

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          RiboCor

                          Country arrow
                          The MedTech Conference
                          Not Confirmed

                          RiboCor

                          Country arrow
                          The MedTech Conference
                          Not Confirmed

                          Details : D-Ribose is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Fibromyalgia.

                          Product Name : Undisclosed

                          Product Type : Carbohydrate

                          Upfront Cash : Inapplicable

                          March 15, 2011

                          Lead Product(s) : Ribose

                          Therapeutic Area : Musculoskeletal

                          Highest Development Status : Phase II

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Kona Research Center

                          Country arrow
                          The MedTech Conference
                          Not Confirmed

                          Kona Research Center

                          Country arrow
                          The MedTech Conference
                          Not Confirmed

                          Details : Ribose is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Fibromyalgia.

                          Product Name : Undisclosed

                          Product Type : Carbohydrate

                          Upfront Cash : Inapplicable

                          April 22, 2010

                          Lead Product(s) : Ribose

                          Therapeutic Area : Musculoskeletal

                          Highest Development Status : Undisclosed

                          Sponsor : Bioenergy Life Science, Inc. | Integrative Therapeutics

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank